» Articles » PMID: 16385630

Differential Effects of the Tryptophan Metabolite 3-hydroxyanthranilic Acid on the Proliferation of Human CD8+ T Cells Induced by TCR Triggering or Homeostatic Cytokines

Overview
Journal Eur J Immunol
Date 2005 Dec 31
PMID 16385630
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Production of indoleamine 2,3-dioxygenase (IDO) by tumor cells, leading to tryptophan depletion and production of immunosuppressive metabolites, may facilitate immune tolerance of cancer. IDO gene is also expressed in dendritic cells (DC) upon maturation induced by lipopolysaccarides or IFN. We investigated IDO gene expression in melanoma cell lines and clinical specimens as compared to mature DC (mDC). Furthermore, we explored effects of L-kynurenine (L-kyn) and 3-hydroxyanthranilic acid (3-HAA) on survival and antigen-dependent and independent proliferation of CD8(+) cells. We observed that IDO gene expression in cultured tumor cells and freshly excised samples is orders of magnitude lower than in mDC, providing highly efficient antigen presentation to CD8(+) T cells. Non toxic concentrations of L-kyn or 3-HAA did not significantly inhibit antigen-specific CTL responses. However, 3-HAA, but not L-kyn markedly inhibited antigen-independent proliferation of CD8(+) T cells induced by common receptor gamma-chain cytokines IL-2, -7 and -15. Our data suggest that CD8(+) T cell activation induced by antigenic stimulation, a function exquisitely fulfilled by mDC, is unaffected by tryptophan metabolites. Instead, in the absence of effective T cell receptor triggering, 3-HAA profoundly affects homeostatic proliferation of CD8(+) T cells.

Citing Articles

3-Hydroxyanthranic acid inhibits growth of oral squamous carcinoma cells through growth arrest and DNA damage inducible alpha.

Gan G, Zhou X, Zheng Q, Gao X, Chen X, Zhang H Transl Oncol. 2025; 52:102278.

PMID: 39799750 PMC: 11770551. DOI: 10.1016/j.tranon.2025.102278.


Immunometabolism: signaling pathways, homeostasis, and therapeutic targets.

Xu R, He X, Xu J, Yu G, Wu Y MedComm (2020). 2024; 5(11):e789.

PMID: 39492834 PMC: 11531657. DOI: 10.1002/mco2.789.


Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment.

Zheng Y, Xu R, Chen X, Lu Y, Zheng J, Lin Y Cell Death Dis. 2024; 15(10):775.

PMID: 39461979 PMC: 11513100. DOI: 10.1038/s41419-024-07122-6.


Systematic Insights into the Relationship between the Microbiota-Gut-Brain Axis and Stroke with the Focus on Tryptophan Metabolism.

Shen X, Mu X Metabolites. 2024; 14(8).

PMID: 39195495 PMC: 11356289. DOI: 10.3390/metabo14080399.


The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer.

Leon-Letelier R, Dou R, Vykoukal J, Sater A, Ostrin E, Hanash S Front Oncol. 2023; 13:1256769.

PMID: 37876966 PMC: 10591110. DOI: 10.3389/fonc.2023.1256769.